Clinic Schizophrenia Group

ORCID Research Profile


Position: Director of Barcelona

Clinic Schizophrenia Unit;

Full Professor of Psychiatry

Research team


Rosa Catalan Campos

Assistant Professor

rosacatalan (at) ub.edu


Eduardo Parellada Rodon

Assistant Professor

eduardparelladarodon (at) ub.edu


Rafael Penades Rubio

Assistant Professor

rafaelpenades (at) ub.edu


Mercè Torra Santamaria

Assistant Professor

mtorra (at) ub.edu


Silvia Amoretti Guadall


amoretti (at) clinic.cat


Miquel Bioque Alcazar



Clemente Garcia Rizo



Bibiana Cabrera Llorca



Gisela Mezquida Mateos



Alexander Gonzalez Rodriguez


Contact details


Prof. Miquel Bernardo Arroyo

Department of Psychiatry and Clinical Psychobiology

Faculty of Medicine, Casanovas 143

08036 Barcelona (Spain)

+ 34 93 227 54 00 # 3142

bernardo (at) clinic.ub.es



Research Interests


The Clinical Schizophrenia Group (GEC) has been recognized as a consolidated research group since 2005 (2014SGR 441) by the Agència de Gestió d’Ajuts Universitaris i de Recerca, AGAUR. This interdisciplinary group focuses on schizophrenia and related disorders in clinical care, research and teaching. The research is centered on the study of first episodes, childhood and adolescent-onset, resistant and comorbid schizophrenia. The main lines include neuroimaging, genetics, neurobiology and molecular psychiatry; neuropsychology, psychoeducation and psychometric evaluation; psychopharmacology; physical health; high-risk population, A program has been developed for characterizing and preventing second psychotic episodes.  We have active collaboration (multicenter studies in translational and innovative investigation) with other IDIBAPS, CIBERSAM, and international research groups. We collaborate with a European network of research in schizophrenia and maintain close relationship to American research networks.

Current Research Lines


  • Physical health
  • Neuroimaging, genetics and neurobiology, molecular psychiatry
  • Neuropsychology, psychoeducation and psychometric evaluation
  • Psychopharmacology
  • High-risk population, early-onset and first and second episodes of psychosis

Technologies / methods


  • Functional and structural neuroimaging techniques.
  • Genetic and molecular biological techniques. Patent acquired by AB-Biotics and developed by UB, IDIBAPS, Hospital Clínic and CIBERSAM. Method for predicting the onset extrapiramidal symptoms (EPS) induced by an antipsychotic-based treatment.
  • Psychometric evaluation.

Highlighted publications


· Kirkpatrick B, Miller B, Garcia-Rizo C, Fernandez-Egea E, Bernardo M. (2012)  Is Abnormal Glucose tolerance In Antipsychotic-Naïve with Nonaffective Psychosis Confounded by Poor Health Habits? Schizophr Bull 38(2): 280-284.


· Penades R, Pujol N, Catalán R, Masana G, Rametti G, García-Rizo C, Bargalló N, Gastó C, Bernardo M, Junqué C. (2013) Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol Psychiatry. 15;73(10):1015-23.


· Garcia-Rizo C,Kirkpatrick B, Fernandez-Egea E, Oliveira C, Meseguer A, Grande I, Undurraga J, Vieta E, Bernardo M. (2104). Is bipolar disorder an endocrine condition?: Glucose abnormalities in bipolar disorder. Acta Psychiatrica Scandinavica;129(1):73-74.


· Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, Gonzáles-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A,  Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; andPEPs GROUP. A pharmacovigilancestudy in firstepisode of psychosis; Psychopharmacologicalinterventionsand safety profiles in theproject. Int J Neuropsychopharmacol. 2015 Oct 27.


· Batalla A, Bargalló N, Gassó P, Molina O, Pareto D, Mas S, Roca JM, Bernardo M, Lafuente A, Parellada E. (2015). Apoptoticmarkers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls. Transl Psychiatry. Aug 25;5:e626.